Heavy short interest, proprietary technology

10 בנוב׳ 2014

Now looks like a smart time to be investing in MNKD. Not only is Afrezza a better insulin than many available, not only does the technosphere eliminate a lot of potential unnecessary needles... the technosphere is the potential gold mine here. Imagine the FLU SHOT being a thing of the past... for the new, improved delivery system of a FLU INHALER. FDA can fast track drugs thru using technosphere... its already FDA approved. Many cultures in the world wont even USE a needle. Not to mention, HUGE SHORT INTEREST... once this sets fire, its gonna blaze...